• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.

作者信息

Holtan Shernan G, Versluis Jurjen, Weisdorf Daniel J, Cornelissen Jan J

机构信息

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.

Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.

出版信息

J Clin Oncol. 2021 Feb 10;39(5):373-385. doi: 10.1200/JCO.20.01771. Epub 2021 Jan 12.

DOI:10.1200/JCO.20.01771
PMID:33434075
Abstract
摘要

相似文献

1
Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.优化异基因造血细胞移植中的供体选择和移植物抗宿主病预防
J Clin Oncol. 2021 Feb 10;39(5):373-385. doi: 10.1200/JCO.20.01771. Epub 2021 Jan 12.
2
Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR.无关供者和脐带血造血细胞移植的选择：来自 NMDP/CIBMTR 的指南。
Blood. 2019 Sep 19;134(12):924-934. doi: 10.1182/blood.2019001212. Epub 2019 Jul 10.
3
National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.国家骨髓捐献计划非亲属成年供者造血细胞移植的HLA配型指南。
Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):45-53. doi: 10.1016/j.bbmt.2008.06.014.
4
Advances in haploidentical stem cell transplantation for hematologic malignancies.单倍体相合造血干细胞移植治疗血液系统恶性肿瘤的进展
Leuk Lymphoma. 2016 Aug;57(8):1766-75. doi: 10.3109/10428194.2016.1167204. Epub 2016 Apr 13.
5
[Allogeneic hematopoietic stem cell transplantations].[异基因造血干细胞移植]
Transfus Clin Biol. 2011 Apr;18(2):235-45. doi: 10.1016/j.tracli.2011.02.021. Epub 2011 Apr 3.
6
Role of HLA in hematopoietic SCT.人类白细胞抗原在造血干细胞移植中的作用。
Bone Marrow Transplant. 2008 Oct;42 Suppl 2:S71-6. doi: 10.1038/bmt.2008.288.
7
Donor Selection Based on Killer Cell Immunoglobulin-Like Receptor (KIR) Genotype May Improve Outcome After T-Cell-Replete Haploidentical Transplantation.基于杀伤细胞免疫球蛋白样受体（KIR）基因型的供体选择可能改善富含T细胞的单倍体同基因移植后的结局。
Transplant Proc. 2018 Mar;50(2):679-682. doi: 10.1016/j.transproceed.2017.09.070.
8
Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.低剂量抗胸腺细胞球蛋白预防亲缘全相合异基因造血干细胞移植后移植物抗宿主病
Biol Blood Marrow Transplant. 2017 Dec;23(12):2096-2101. doi: 10.1016/j.bbmt.2017.08.007. Epub 2017 Aug 15.
9
Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.HLA 相合供者选择方面的进展：美国国家骨髓捐献计划登记处头 20 年 HLA 分型与配型的改进
Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):37-44. doi: 10.1016/j.bbmt.2008.05.001. Epub 2008 Jun 20.
10
[Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].[单倍型相合造血干细胞移植：法语国家骨髓移植与细胞治疗协会（SFGM-TC）指南]
Bull Cancer. 2016 Nov;103(11S):S229-S242. doi: 10.1016/j.bulcan.2016.09.007. Epub 2016 Nov 11.

引用本文的文献

1
Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trial.异基因造血干细胞移植后限时与标准疗程免疫抑制：前瞻性随机HOVON-96试验结果
Hemasphere. 2024 Dec 11;8(12):e70040. doi: 10.1002/hem3.70040. eCollection 2024 Dec.
2
PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation.基于PTCy的移植物抗宿主病预防方案用于同胞全相合供者异基因造血细胞移植
Blood Adv. 2025 Feb 11;9(3):660-669. doi: 10.1182/bloodadvances.2024014781.
3
Allogeneic hematopoietic cell transplantation from alternative donors in acute myeloid leukemia.
急性髓系白血病中来自替代供者的异基因造血细胞移植。
Ann Hematol. 2024 Dec;103(12):4851-4868. doi: 10.1007/s00277-024-05944-0. Epub 2024 Aug 17.
4
Screening of single nucleotide polymorphisms within HLA region related to hematopoietic stem cell transplantation using MassARRAY technology.采用 MassARRAY 技术筛选与造血干细胞移植相关的 HLA 区域内的单核苷酸多态性。
Sci Rep. 2023 Apr 11;13(1):5913. doi: 10.1038/s41598-023-33149-4.
5
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.真实世界数据显示异基因造血细胞移植中种族和民族的趋势和结果：来自国际血液和骨髓移植研究中心的报告。
Transplant Cell Ther. 2023 Jun;29(6):346.e1-346.e10. doi: 10.1016/j.jtct.2023.03.007. Epub 2023 Mar 15.
6
Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后 T 细胞反应中的鞘脂代谢。
Front Immunol. 2022 Aug 16;13:904823. doi: 10.3389/fimmu.2022.904823. eCollection 2022.
7
Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry.台湾血液与骨髓移植登记处不同单倍型相合移植策略的结果
Cancers (Basel). 2022 Feb 21;14(4):1097. doi: 10.3390/cancers14041097.
8
Ocular Graft-versus-Host Disease in a Chemotherapy-Based Minor-Mismatch Mouse Model Features Corneal (Lymph-) Angiogenesis.基于化疗的次要匹配小鼠模型中的眼移植物抗宿主病具有角膜（淋）血管生成特征。
Int J Mol Sci. 2021 Jun 8;22(12):6191. doi: 10.3390/ijms22126191.
9
Novel Composite Endpoints after Allogeneic Hematopoietic Cell Transplantation.异基因造血细胞移植后的新型复合终点。
Transplant Cell Ther. 2021 Aug;27(8):650-657. doi: 10.1016/j.jtct.2021.05.005. Epub 2021 May 15.